Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Long-Term-Assets" stands at -18.62 Billion United States Dollars as of 09/30/2025, the lowest value at least since 03/31/2011, the period currently displayed.
As of the end of Johnson & Johnson's third quarter, the item "Other Long Term Assets" stands at -18.62 Billion USD. This represents a decrease of -252.77 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -29.54 Billion United States Dollars compared to the value the year prior.
The 1 year change is -29.54 Billion United States Dollars.
The 3 year change is -27.25 Billion United States Dollars.
The 5 year change is -24.75 Billion United States Dollars.
The 10 year change is -22.42 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Long Term Assets | 905,699,262,464.00 |
![]() | AbbVie Inc - Other Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Assets | 280,205,508,085.11 |
![]() | Novartis AG - Other Long Term Assets | 255,096,620,580.91 |